Skip to main content
Quest DiagnosticsEarnings

Quest Diagnostics stock reports growth as reimbursement risk rises

What happened

Quest Diagnostics reported earnings per share of $2.84 for the second quarter of 2026.

Source

Article excerpt

Highlighted: the sentence this signal was extracted from

Quest Diagnostics stock stood at USD 233 in after-hours trading on September 23, 2026, down USD 1.76 or 0.75 percent from the prior close. The price was 6.37 percent below the 52-week high of USD 248.84, while market capitalization stood at USD 25.716 billion. Quest Diagnostics reported USD 3.043 billion in revenue for Q2 2026, up 10.2 percent from the year-earlier quarter. Reported EPS reached USD 2.84, compared with USD 2.47 in Q2 2025, according to Yahoo Finance . Reported operating income was USD 459 million, equal to 15.1 percent of revenue, versus USD 438 million and 15.9 percent in the prior-year quarter. The combination shows the central tension in the results: revenue growth accelerated, while the reported operating margin narrowed by 0.8 percentage points. After the first half of fiscal 2026, Quest raised its full-year revenue outlook to USD 11.95 billion to USD 12.05 billion, representing growth of 8.3 percent to 9.2 percent. Reported full-year EPS guidance stands at USD 9.97 to USD 10.17, while adjusted EPS guidance is USD 11.05 to USD 11.25, Yahoo Finance reported. The outlook gives the stock a measurable earnings foundation, but the margin comparison keeps execution in view. Wage inflation and other cost drivers reduced operating income as a share of revenue by 70 basis points in the quarter. A separate policy issue has become relevant for the valuation. The...

Keep reading with a free account

The rest of this article, and every signal for Quest Diagnostics, is in your free account.

Extracted by Autobound

From the Signal API record
Event
Earnings

What this signalsEarnings results often set the next budget cycle.

Amount named
$459M
Stories
2

The full record

From the Signal API record

Numbers

Amount named in the story
$459M
Stories about this event
2

Extraction

Confidence
90%
Detected
Sep 24, 2026
signal_type
news
signal_subtype
has_earnings

Use this data

Get every earnings signal for Quest Diagnostics and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Quest Diagnostics this week?”

  2. Send it to your own tools

    The Signal API returns earnings signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/320c58c2-795e-cd23-91a5-a6f4efe3bb92 returns this record as JSON. POST /v1/companies/enrich returns every signal for questdiagnostics.com.

{
  "signal_id": "320c58c2-795e-cd23-91a5-a6f4efe3bb92",
  "signal_type": "news",
  "signal_subtype": "has_earnings",
  "detected_at": "2026-09-24T08:50:31+00:00",
  "company": {
    "name": "Quest Diagnostics",
    "domain": "questdiagnostics.com"
  },
  "data": {
    "url": "https://www.ad-hoc-news.de/boerse/news/corporate-news/quest-diagnostics-stock-reports-growth-as-reimbursement-risk-rises/70176273",
    "title": "Quest Diagnostics stock reports growth as reimbursement risk rises - AD HOC NEWS",
    "excerpt": "Quest Diagnostics stock stood at USD 233 in after-hours trading on September 23, 2026, down USD 1.76 or 0.75 percent from the prior close. The price was 6.37 percent below the 52-week high of USD 248.84, while market capitalization stood at USD 25.716 billion. Quest Diagnostics reported USD 3.043 billion in revenue for Q2 2026, up 10.2 percent from the year-earlier quarter. Reported EPS reached USD 2.84, compared with USD 2.47 in Q2 2025, according to Yahoo Finance . Reported operating income was USD 459 million, equal to 15.1 percent of revenue, versus USD 438 million and 15.9 percent in the prior-year quarter. The combination shows the central tension in the results: revenue growth accelerated, while the reported operating margin narrowed by 0.8 percentage points. After the first half of fiscal 2026, Quest raised its full-year revenue outlook to USD 11.95 billion to USD 12.05 billion, representing growth of 8.3 percent to 9.2 percent. Reported full-year EPS guidance stands at USD 9.97 to USD 10.17, while adjusted EPS guidance is USD 11.05 to USD 11.25, Yahoo Finance reported. The outlook gives the stock a measurable earnings foundation, but the margin comparison keeps execution in view. Wage inflation and other cost drivers reduced operating income as a share of revenue by 70 basis points in the quarter. A separate policy issue has become relevant for the valuation. The...",
    "summary": "Quest Diagnostics reported earnings per share of $2.84 for the second quarter of 2026.",
    "planning": false,
    "image_url": "https://mdb.ad-hoc-news.de/bild/bild-2702276_1920_1080.webp",
    "confidence": 0.9,
    "published_at": "2026-09-24T08:50:31Z",
    "article_sentence": "Reported EPS reached USD 2.84, compared with USD 2.47 in Q2 2025, according to Yahoo Finance ."
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.